Qing Zhou

31PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 10, 2026
The effects of probiotics duration and type on immunotherapy efficacy in non-small cell lung cancer with or without antibiotics.

|Jun 08, 2026
Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025.

|May 14, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based <i>MET</i> Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.

|Feb 25, 2026
SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer.

Qing Zhou, Bo Gao, Jie Hu

|Nov 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.

Yang-Si Li, Wenpu Lai, Kai Yin

|Oct 24, 2025
C1orf116 inhibits acquired resistance to EGFR inhibitors in EGFR mutant lung adenocarcinoma by suppressing the ATM/ATR pathways.

Fen Wang, Chang Lu, Xiaorong Yang

Pageof 6

Frequent Collaborators

13 joint publications

Yi-Long Wu

7 joint publications

Xu-Chao Zhang

6 joint publications

Jia-Tao Zhang

6 joint publications

Siyang Maggie Liu